ANALISIS EKSPRESI TRANSPORTER ZINK (ZNT-1) SEBAGAI FAKTOR PROGNOSIS ADENOKARSINOMA PROSTAT
Abstract
Keywords
Full Text:
PDFReferences
Globocan.Iarc.Fr [internet]. International Agency for Research on Cancer. GLOBOCAN 2008: Estimated cancer incidence, mortality and prevalence worldwide in 2012. [cited 2012 Dec 3]. Avaible from http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
Globocan.Iarc.Fr [internet]. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. [cited 2014 Jan 17].Avaible from http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
Kumar, Abbas, Fausto, Aster. Robbins and cotran pathologic basis of disease. 8th ed. Philadelphia: Saunders; 2010.
Franz MC, Anderle P, Burzle M. Zinc transporters in prostate cancer. Mol Aspects Med. 2013;34:735-41.
Palmiter RD, Huang L. Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers. Eur J Physiol. 2004;447:744-51.
Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer. 2006;55:17
Pizem J, Cor A. Detection of apoptotic cells in tumour paraffin sections. Radiol Oncol. 2003;37:225-32.
Santamaria L, Martin R, Gomez V. Stereologic estimation of KI-67, caspase 3, and GSTP1 positive cells in prostate lesions. Image Anal Stereol. 2005;24:77-84.
Septiawan DA. Analisis ekspresi protein ZIP1 dan Caspase-3 pada adenokarsinoma prostat (Tesis). 2013.
Hasumi M, Suzuki K, Matsui H. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Letters. 2003;200:187-95.
Winter RN, Kramer A, Borkowski A. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res. 2001;61:1227-32.
Da Motta VP, Malafaia O, Ribas-Filho JM. Caspase-3 and CD-34 expression in prostate adenocarcinoma. Rev Col Bras Cir. 2009;36:223-9.
Langmade SJ, Ravindra R, Daniels PJ. The transcription factor MTF-1 mediates metal regulations of the mouse ZnT1 gene. J Biol Chem. 2000;275:34803-9.
Cortesi M, Fridman E, Volkov A, Shilstein S, Chechik R. New prospective for non-invasive detection, grading, size evaluation, and tumor location of prostate cancer. Prostate. 2010;70(15):1701-8.
Chasapis CT, Loutsidou AC, Spiliopoulou, Stefanidou ME. Zinc and human health: an update. Arch Toxicol. 2012;86:521-34.
Costello LC, Franklin RB. The important role of the apoptotic effects of zinc in the development of cancers. J Cell Biochem. 2009;106(5):750-57.
Ananthanarayanan V, Deaton RJ, Yang XJ, Pins MR, Gann PH. Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer. 2006;6(73).
Kosova F, Temeltas G, Ari Z, Lekili M. Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patiens. Tumor Biol. 2014;35:4259-99.
Mihelich LB, Khramtsova EA, Arva N, Vaishnav A, Johnson DN. miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. J Biol Chem. 2011;286:44503-11.